Assessing rates of hypoglycemia as an end point in clinical trials.
Kinexum, La Jolla, CA lajollaendollc@gmail.com.
Douglas B
DB
Muchmore
Science & Co, Düsseldorf, Germany.
Lutz
L
Heinemann
Yale School of Medicine, New Haven, CT.
William
W
Tamborlane
Halozyme Therapeutics, San Diego, CA.
Xionghua W
XW
Wu
Kinexum, Harpers Ferry, WV.
Alexander
A
Fleming
D001786:Blood Glucose / Q000378:metabolism; D015190:Blood Glucose Self-Monitoring; D002986:Clinical Trials as Topic; D023381:Endpoint Determination; D006801:Humans; D007003:Hypoglycemia / Q000097:blood / Q000175:diagnosis*
D001786:Blood Glucose